Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
about
PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture.Postoperative tamoxifen for ductal carcinoma in situPost-operative radiotherapy for ductal carcinoma in situ of the breastPost-operative radiotherapy for ductal carcinoma in situ of the breastNSABP breast cancer clinical trials: recent results and future directionsThe diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesionsDuctal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomesBiomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosisModeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.Structural estimates of treatment effects on outcomes using retrospective data: an application to ductal carcinoma in situ.Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situSignificance of immunohistochemistry in breast cancerTreatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?Regression of ductal carcinoma in situ after treatment with acupunctureEffect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plansLong-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.Communication between patients and providers and informed decision making.Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situRadiation therapy for ductal carcinoma in situ: a decision analysisStudy of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast CancerFuture medical applications of single-cell sequencing in cancer.Therapeutic potential of tyrosine kinase inhibitors in breast cancer.Use of tamoxifen before and during pregnancyIntraductal therapy of ductal carcinoma in situ: a presurgery study.Patterns and correlates of local therapy for women with ductal carcinoma-in-situEffect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysisEvaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.Role of the radiotherapy boost on local control in ductal carcinoma in situClinical outcomes of ductal carcinoma in situ of the breast treated with partial mastectomy without adjuvant radiotherapyPerioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancerCharacterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.Ductal carcinoma in situ: what can we learn from clinical trials?
P2860
Q22000770-007ECD03-79BC-43FA-A0FD-D10E7A72F8BFQ24198028-44CA0210-74B0-41FF-8D8A-E142FB9E1916Q24202386-AD5567D5-D4BE-433B-93AF-53BF1AFF0C75Q24240332-CB79F10D-0799-4B37-834B-9449B9D0A7E6Q24520573-D133DFD3-7267-43F1-A9FC-61924E72380DQ24802837-66826599-D477-4855-862B-A915069CFD71Q28270358-7E3CA350-2315-4A6A-A878-B777536C0A32Q28280822-7FFB0391-1E62-4A64-A567-BAEDEFE3ABE3Q30370779-0FCCF40F-2AC3-4FD1-BC44-31F7A67C0CC6Q30692732-299B3A0F-DFF1-49E2-BB7F-6039F9693786Q33293401-74AB7C5F-6699-49EA-9824-60B2492A2280Q33627178-AC54C61C-7FAC-4574-8ABE-4E7876525459Q33907988-7D750E02-41CD-4CFA-9643-56F8BEBFF169Q33924710-E0BF69E3-E867-4477-973E-3D1BE63D9C6BQ34023682-A212F323-2122-430B-9A49-1280CE3B75EEQ34038325-34352738-FDFC-44BA-86EA-E371806BA965Q34335729-F958681F-A513-41ED-B298-1927EAA37345Q34478845-5F118BBB-C546-42D6-83EB-CEAB3B14B53EQ34498792-474DD82F-6A36-4652-8B1D-2FF41FEFD4F1Q34989912-B730BA2B-CAB7-4854-B10F-B525F7391FEDQ35023352-FA4F1AE0-1CA3-47F4-BB48-E64C331D8E94Q35119776-9250B7B4-D0EF-461B-B47F-FDDA59FE9460Q35184951-39A2C1A4-4795-4615-8D68-FA4EF108A3DDQ35293322-C0876430-CE94-4B3A-B5F9-CA6E211647A0Q35431358-04A7909D-A643-45DB-B4C1-9D56F48B9B96Q35558519-CEE1BB15-193D-46C5-8501-8C7ABF4FA81AQ35589209-41DBF286-3166-4076-A5CF-1A0DF0C27C0AQ35599785-08D4EF49-46A7-4F62-B888-3060CB3BD5AAQ35637342-120B84E6-30A8-43C1-9B5D-CE5049899FECQ35674899-26A41597-F4CB-4A18-9930-7461070B80A1Q35743243-D89D62CF-9DE8-47DD-9669-A43A3E1AFEBAQ35808405-DD680ADE-39EF-4F86-99FC-A0B77E5708ABQ35816292-A1E68C6B-786C-43A9-B52B-FBAF3143A396Q35837432-9CEC0C45-68B1-4517-84B5-A91EC13D3034Q35904098-BF5DBC77-39AB-4697-BA06-8ACE4D69B397Q35932105-15F4525C-4293-4C6A-8B61-432A46F33791Q35945018-150D4FF8-D90D-4AA3-AEE1-94544167EC82Q35945945-E70B29F6-F4D2-43D6-9098-FA22D7B02409Q35963338-B103364A-2726-4B88-9DCA-087BBD715590Q35977573-F7E269C9-E1FB-46FF-B785-CA7D7580AB9D
P2860
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Prevention of invasive breast ...... and Bowel Project experience.
@en
Prevention of invasive breast ...... and Bowel Project experience.
@nl
type
label
Prevention of invasive breast ...... and Bowel Project experience.
@en
Prevention of invasive breast ...... and Bowel Project experience.
@nl
prefLabel
Prevention of invasive breast ...... and Bowel Project experience.
@en
Prevention of invasive breast ...... and Bowel Project experience.
@nl
P2093
P1433
P1476
Prevention of invasive breast ...... and Bowel Project experience.
@en
P2093
P304
P356
10.1016/S0093-7754(01)90133-2
P577
2001-08-01T00:00:00Z